Home › High Blood Pressure › Missouri › Columbia
High Blood Pressure clinical trials in Columbia, MO
4 studies for High Blood Pressure are looking for participants at sites in and around Columbia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Jefferson City Medical Group, Jefferson City · 27 mi away
Impact GLP-1 Agonists Following Bariatric
RecruitingPhase 4
- University of Missouri Hospital, Columbia
Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
RecruitingObservational study
- University of Missouri, Columbia
An Open-label Extension Safety and Efficacy Study of QCZ484 in Hypertensive Patients.
RecruitingPhase 2
- Jefferson City Medical Group, Jefferson City · 27 mi away
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Birmingham, AL11 studies
- Houston, TX11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Columbia
- Obesity12 studies
- Non-Small Cell Lung Cancer8 studies
- Colorectal Cancer7 studies
- Myasthenia Gravis6 studies
- Cancer (all types)6 studies
- Type 2 Diabetes6 studies
- Breast Cancer6 studies
- Steatotic Liver Disease5 studies
- Heart Failure5 studies
- Cardiovascular Disease5 studies
- Lung Cancer5 studies
- Cerebral Hemorrhage4 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.